pefloxacin has been researched along with Bronchial Pneumonia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vanderdonckt, J | 1 |
| Catena, E; de Iola, G; Ginesu, F; Gori, M; Grassi, C; Lucchini, M; Mangiarotti, P; Micillo, E; Onoscuri, M; Orlandi, O | 1 |
| Chopin, C; Fourrier, F; Lestavel, P; Savage, C | 1 |
| Fourrier, F; Gouin, F; Junginger, W; Martin, C; Prieur, BL | 1 |
| Lauwers, S; Naessens, A; Pierard, D; Vincken, W | 1 |
3 trial(s) available for pefloxacin and Bronchial Pneumonia
| Article | Year |
|---|---|
Comparison of pefloxacin with ceftazidime in severe bronchopulmonary infections.
Topics: Administration, Oral; Bacterial Infections; Bronchopneumonia; Ceftazidime; Drug Resistance, Microbial; Female; Humans; Injections, Intravenous; Male; Middle Aged; Pefloxacin; Prospective Studies; Remission Induction | 1990 |
Pefloxacin in lower respiratory tract infections.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Bronchitis; Bronchopneumonia; Chronic Disease; Female; Humans; Injections, Intravenous; Male; Middle Aged; Pefloxacin; Pleurisy; Pneumonia | 1990 |
[Initial antibiotherapy in severe bacterial bronchopneumopathies. Randomized study of a new quinolone: pefloxacin].
Topics: Anti-Infective Agents; Bacterial Infections; Bronchopneumonia; Humans; Norfloxacin; Pefloxacin | 1986 |
2 other study(ies) available for pefloxacin and Bronchial Pneumonia
| Article | Year |
|---|---|
Pefloxacin in the treatment of nosocomial lower respiratory tract infections in intensive care patients.
Topics: Adolescent; Adult; Aged; Bronchopneumonia; Cross Infection; Female; Humans; Lung Abscess; Male; Middle Aged; Norfloxacin; Pefloxacin; Pneumonia; Prospective Studies; Respiration, Artificial | 1988 |
Efficacy and safety of pefloxacin in the treatment of severe infections in patients hospitalized in intensive care units.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bronchopneumonia; Cholangitis; Drug Evaluation; Female; Humans; Intensive Care Units; Male; Middle Aged; Norfloxacin; Pefloxacin; Pneumonia | 1986 |